-
Sinovac to apply for clinical trial of Delta-specific vaccine in Q3: general manager
firstwordpharma
August 16, 2021
Sinovac plans to submit clinical application materials for its inactivated COVID-19 vaccine especially for the Delta variant to authorities in the third season this year, reported the Global Times.
-
Sinovac's COVID-19 vaccine 58.5% effective in preventing illness -Chile real world study
firstwordpharma
August 04, 2021
Chilean health authorities said on Tuesday that Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic infection among millions of Chileans who received it between February and July, as reported This is Money
-
Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac
contractpharma
July 21, 2021
Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.
-
Sinopharm and Sinovac to deliver 550 million vaccine doses to Gavi
pharmaceutical-technology
July 14, 2021
Gavi, the Vaccine Alliance has signed advance purchase agreements (APAs) for a total of up to 550 million doses of Covid-19 vaccines from Sinopharm and Sinovac for supply through the COVAX facility.
-
SINOVAC signs agreement to supply CoronaVac to COVAX
expresspharma
July 13, 2021
SINOVAC Biotech announced that it has signed an advance purchase agreement (APA) with Gavi, the Vaccine Alliance, which is on behalf of COVAX Facility, to provide up to 380 million doses of inactivated COVID-19 vaccine, CoronaVac for distribution ...
-
Philippines gets 1 million more Sinovac doses
firstwordpharma
June 07, 2021
The Philippines on Sunday received 1 million more doses of Sinovac's COVID-19 vaccine as part of its procurement of the vaccine, as reported The Philippine Star.
-
WHO authorises Sinovac’s COVID-19 vaccine for emergency use
pharmatimes
June 03, 2021
The World Health Organization (WHO) has validated Sinvoc’s COVID-19 vaccine for emergency use in adults aged 18 years and older in a two-dose schedule with a spacing of two to four weeks.
-
Sinovac COVID-19 vaccine gets WHO validation for emergency use
expresspharma
June 02, 2021
WHO’s Emergency Use Listing (EUL) is a prerequisite for COVAX Facility vaccine supply and international procurement.
-
Sinovac Biotech vaccine effective in controlling Covid-19, new study shows
firstwordpharma
June 01, 2021
Preliminary numbers show that Sinovac’s vaccine was effective in controlling COVID-19 in a mass-inoculation study in a small Brazilian town after 75% of adults were covered with a second shot, as reported by The Irish Times.
-
Sinovac’s Covid-19 vaccine prevents 67% symptomatic infections in study
pharmaceutical-technology
April 20, 2021
The Chilean Ministry of Health has reported that the Chinese pharmaceutical company Sinovac Covid-19 vaccine CoronaVac demonstrated to be up to 67% effective in preventing symptomatic infections in a study.